SCHEMBL6882249

SCHEMBL6882249

CNC(=O)c1cnccc1-c1ccccc1C

nearest known ligand 0.48

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.48
TYK2 P29597 1/20 0.48
TACR1 P25103 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
SIRT3 Q9NTG7 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
GPBAR1 Q8TDU6 12/20 0.46
KMT2A Q03164 1/20 0.44
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
ATM Q13315 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6862976 0.88 TACR1 (0.47) MAPK1TYK2TACR1L3MBTL1GPBAR1
SCHEMBL6637548 0.83 SIRT3 (0.50) TYK2TACR1SIRT3TDP1GPBAR1
SCHEMBL29971293 0.82 GAA (0.53) MAPK1L3MBTL1KMT2AALDH1A1LMNA
SCHEMBL30107188 0.82 SIRT3 (0.61) MAPK1TYK2L3MBTL1SIRT3TDP1
SCHEMBL13162016 0.82 SIRT3 (0.61) MAPK1TYK2L3MBTL1SIRT3TDP1
SCHEMBL6641437 0.82 ALDH1A1 (0.50) TYK2TACR1L3MBTL1SIRT3TDP1
SCHEMBL6825048 0.81 SIRT3 (0.67) TACR1SIRT3TDP1GPBAR1
SCHEMBL905344 0.75 GPBAR1 (0.50) TYK2L3MBTL1GPBAR1KMT2A
SCHEMBL28743630 0.75 POLQ (0.46) TYK2L3MBTL1KMT2AALDH1A1
SCHEMBL30674829 0.75 KDM4C (0.49) MAPK1TYK2L3MBTL1SIRT3TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1293056-C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists HOFFMANN LA ROCHE (CH) 2007-01-03 CN disclosed
CN-1610670-A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists HOFFMANN LA ROCHE (CH) 2005-04-27 CN disclosed
EP-1406618-A2 USE OF NK-1 RECEPTOR ANTAGONISTS WITH PYRIDINIC STRUCTURE FOR THE TREATMENT OF BRAIN, SPINAL OR NERVE INJURY F. HOFFMANN-LA ROCHE AG (CH) 2004-04-14 EP disclosed
WO-2003006016-A2 USE OF NK-1 RECEPTOR ANTAGONISTS WITH PYRIDINIC STRUCTURE, FOR THE TREATMENT OF BRAIN, SPINAL OR NERVE INJURY F. HOFFMANN-LA ROCHE AG (CH) 2003-01-23 WO disclosed